GWS
ONC

Glassman Wealth Services’s BeOne Medicines Ltd ONC Stock Holding History

Glassman Wealth Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed -$5.41K – 1907
2023
Q4 		$5.41K Sell
30
-4
-12% -$724 ﹤0.01% 1054
2023
Q3 		$6.12K Buy
34
+12
+55% +$2.37K ﹤0.01% 1000
2023
Q2 		$3.92K Hold
22
– – ﹤0.01% 1060
2023
Q1 		$4.74K Buy
22
+3
+16% +$720 ﹤0.01% 1013
2022
Q4 		$4.18K Buy
19
+17
+850% +$3.12K ﹤0.01% 1070
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2038
2022
Q2 		$0 Buy
+2
New +$312 ﹤0.01% 2058
2022
Q1 		– Sell
-2
Closed -$1K – 2000
2021
Q4 		$1K Buy
2
+1
+100% +$338 ﹤0.01% 1552
2021
Q3 		$0 Buy
+1
New +$327 ﹤0.01% 1852

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Glassman Wealth Services's ONC Position: Q1 2024 in Review

Glassman Wealth Services sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 30 shares — an estimated $5.41K sold.

Glassman Wealth Services first reported a position in ONC in Q3 2021 and held it in 9 quarters. The position peaked at $6.12K in Q3 2023. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Glassman Wealth Services reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 30 BeOne Medicines Ltd shares in Q1 2024, an estimated $5.41K.
  • Glassman Wealth Services first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 9 quarters.
  • Glassman Wealth Services's BeOne Medicines Ltd position peaked at $6.12K in Q3 2023.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.